Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
ProVen Pharma is a private healthcare and life science services company focused on pharmaceutical distribution and commercialization support rather than novel drug R&D. The company provides specialty distribution, clinical trial comparator and reference drug sourcing, third-party logistics, and outsourced commercial services such as inside sales, marketing, customer service, and technology consulting. Its website emphasizes regulated pharmaceutical wholesaling, FDA-registered trading partner status, and compliance infrastructure supported by TraceLink. Historically, the company also commercialized diagnostic products, including U.S. distribution of the Clungene COVID-19 rapid serology test. Available sources indicate the business has been acquired by Prothya Biosolutions Netherlands but continues to operate as an active sub-organization under the ProVen/Proven branding.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on ProVen Pharma.